glp-1 agonists for diabetes Clinical Focus on in Type 2 Mellitus GLP-1R and Diabetes
Description
Endocr Connect 10(7):R200R212
Because they have personally experienced a reduced desire for food, they are more likely to anticipate a decline in overall demand, translating into lower revenues and profitability expectations for restaurants, grocery stores, and food manufacturers
Consistent with this, certain effectors of the Wnt pathway, including lithium and -catenin, enhance Gcg expression in intestinal but not pancreas-derived cell lines, supposedly via inhibition of the glycogen synthase kinase-3beta (GSK-3beta) [132,133]
doi: 10.1210/en.2011-1464
